![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurre... Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. Show more
LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Wells Fargo...
– ARCALYST® (rilonacept) Q2 2024 net product revenue of $103.4 million, representing 90% year-over-year growth –– ARCALYST 2024 expected net product revenue increased to $405 - $415 million...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.75 | -6.55922038981 | 26.68 | 27.25 | 24.52 | 270252 | 26.00699478 | CS |
4 | 0.11 | 0.44319097502 | 24.82 | 27.92 | 24.51 | 285901 | 26.21473907 | CS |
12 | 6.36 | 34.2487883683 | 18.57 | 27.92 | 17.38 | 482941 | 23.18198827 | CS |
26 | 4.61 | 22.687007874 | 20.32 | 27.92 | 16.56 | 412671 | 21.25716083 | CS |
52 | 7.95 | 46.8197879859 | 16.98 | 27.92 | 14.12 | 405821 | 19.50209158 | CS |
156 | 12.63 | 102.682926829 | 12.3 | 27.92 | 7.36 | 389514 | 15.29852817 | CS |
260 | 15.95 | 177.616926503 | 8.98 | 33 | 5.01 | 377715 | 15.87780853 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions